Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05087810 · ClinicalTrials.gov registry record
Stress and Anxiety Effects on Overactive Bladder
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- 97
- Enrollment target
NCT05087810: Clinical Trial study, sponsored by Vanderbilt University Medical Center.
NCT05087810 is a clinical trial that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 97 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05087810 was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- 97 participants
- Enrollment target
Study Summary
The purpose of this study is to assess how psychological stress and anxiety relate to bladder sensitivity and to psychological burdens in people with overactive bladder and how this can be measured effectively. UPDATE: June 2024 - Upon guidance from the NIDDK, this record was updated to an observational study as it was determined not to be an interventional clinical trial.
Primary Outcome
Changes to bladder sensation prompted by acute psychological stress tasks as measured by degree of perception of bladder fullness (100 point scale)
Interventions
- BEHAVIORAL Psychological stress induction
- OTHER Accelerated oral hydration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2023-02-16 |
| Est. Completion | 2024-06-05 |
Why NCT05087810 stopped before completion
NCT05087810 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 97 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Psychological stress induction is the first listed.
NCT05087810 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05087810 about?
NCT05087810 is a clinical study titled "Stress and Anxiety Effects on Overactive Bladder". The purpose of this study is to assess how psychological stress and anxiety relate to bladder sensitivity and to psychological burdens in people with overactive bladder and how this can be measured effectively. UPDATE: June 2024 - Upon guidance from the NIDDK, this record was updated to an observati...
What is the current status of trial NCT05087810?
This trial is currently terminated. The enrollment target is 97 participants. The study started on 2023-02-16. Estimated completion is 2024-06-05.
What interventions are being tested in trial NCT05087810?
The interventions under investigation include: Psychological stress induction (BEHAVIORAL), Accelerated oral hydration (OTHER).
Who is sponsoring clinical trial NCT05087810?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI